Euromedis Groupe
ALEMG.PA · PAR
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.05 | -0.00 | 0.00 |
| FCF Yield | 0.00% | 6.60% | 0.00% | -26.48% |
| EV / EBITDA | -1.06 | -7.57 | 36.85 | -0.54 |
| Quality | ||||
| ROIC | 3.63% | -1.87% | -0.07% | -12.72% |
| Gross Margin | -24.07% | 34.19% | 18.26% | 5.04% |
| Cash Conversion Ratio | – | -1.50 | – | 0.39 |
| Growth | ||||
| Revenue 3-Year CAGR | -38.88% | -35.19% | -23.02% | -15.74% |
| Free Cash Flow Growth | -100.00% | 0.00% | 100.00% | -94.73% |
| Safety | ||||
| Net Debt / EBITDA | 1.40 | 34.51 | -51.37 | 2.25 |
| Interest Coverage | 3.13 | -4.60 | -0.37 | -19.53 |
| Efficiency | ||||
| Inventory Turnover | 1.86 | 1.20 | 0.96 | 2.31 |
| Cash Conversion Cycle | 53.02 | 59.06 | 86.04 | 52.78 |